In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 28th, 2010 | 20 | No |
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.30 | 3.36 | -10.15 | 1 | 5 | 0 | 68 | 271.272 | 2 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CCNA1-1-E | Cyclin A1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 787 | 0.43 | Binding ≤ 10μM |
CCNA2-1-E | Cyclin A2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 787 | 0.43 | Binding ≤ 10μM |
CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 787 | 0.43 | Binding ≤ 10μM |
GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 270 | 0.46 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CCNA1_HUMAN | P78396 | Cyclin A1, Human | 787 | 0.43 | Binding ≤ 1μM |
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 787 | 0.43 | Binding ≤ 1μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 787 | 0.43 | Binding ≤ 1μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 259 | 0.46 | Binding ≤ 1μM |
CCNA1_HUMAN | P78396 | Cyclin A1, Human | 787 | 0.43 | Binding ≤ 10μM |
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 787 | 0.43 | Binding ≤ 10μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 787 | 0.43 | Binding ≤ 10μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 259 | 0.46 | Binding ≤ 10μM |
Description | Species |
---|---|
Activation of ATR in response to replication stress | |
Activation of the pre-replicative complex | |
AKT phosphorylates targets in the cytosol | |
APC truncation mutants have impaired AXIN binding | |
AXIN missense mutants destabilize the destruction complex | |
Beta-catenin phosphorylation cascade | |
CDK-mediated phosphorylation and removal of Cdc6 | |
Constitutive PI3K/AKT Signaling in Cancer | |
CRMPs in Sema3A signaling | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin E associated events during G1/S transition | |
Degradation of beta-catenin by the destruction complex | |
disassembly of the destruction complex and recruitment of AXIN to the membrane | |
DNA Damage/Telomere Stress Induced Senescence | |
E2F mediated regulation of DNA replication | |
Factors involved in megakaryocyte development and platelet production | |
G0 and Early G1 | |
G1/S-Specific Transcription | |
G2 Phase | |
Meiotic recombination | |
misspliced GSK3beta mutants stabilize beta-catenin | |
Orc1 removal from chromatin | |
p53-Dependent G1 DNA Damage Response | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 com | |
Regulation of APC/C activators between G1/S and early anaphase | |
Regulation of HSF1-mediated heat shock response | |
S33 mutants of beta-catenin aren't phosphorylated | |
S37 mutants of beta-catenin aren't phosphorylated | |
S45 mutants of beta-catenin aren't phosphorylated | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Senescence-Associated Secretory Phenotype (SASP) | |
T41 mutants of beta-catenin aren't phosphorylated | |
truncations of AMER1 destabilize the destruction complex |
No pre-computed analogs available. Try a structural similarity search.